Lawrence Alan Reiter

USPTO Granted Patents = 20 (Patent Applications = 28)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 180(Granted Patents)

Location History:

Gales Ferry, CT (US) (1984 - 1985)
Mystic, CT (US) (1989 - 2022)

Company Filing History:

The General Hospital Corporation

patents

4. 1 out of 8,369

Massachusetts Institute of Technology

patents

5. 1 out of 1

Xtuit Pharmaceuticals, Inc.

patent

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1984-2024

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12116358 - Substituted indoles and methods of use thereof (2024-10-15),

2. 11433136 - Polyacetal polymers, conjugates, particles and uses thereof (2022-09-06),

3. 8431597 - Benzimidazole derivatives (2013-04-30),

4. 8148401 - Benzimidazole derivatives (2012-04-03),

5. 7119201 - Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors (2006-10-10),

6. 6706723 - Pyrimidine-2,4,6-trione metalloproteinase inhibitors (2004-03-16),

7. 6342521 - 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides (2002-01-29),

8. 6197810 - 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides (2001-03-06),

9. 6156798 - Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives (2000-12-05),

10. 6147061 - Phosphinate based inhibitors of matrix metalloproteases (2000-11-14),

11. 6087392 - (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides (2000-07-11),

12. 5739280 - Para-nitroanilide peptides (1998-04-14),

13. 5550152 - Benzopyran and related LTB.sub.4 antagonists (1996-08-27),

14. 5498695 - Paranitroaniline peptides (1996-03-12),

15. 5270331 - Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides (1993-12-14),

Title: The Innovative Contributions of Lawrence Alan Reiter

Introduction: Lawrence Alan Reiter, an accomplished inventor based in Mystic, Connecticut, holds an impressive portfolio of 20 patents. His work has notably advanced fields related to pharmaceuticals and material science, demonstrating his commitment to innovation and enhancing medical treatments.

Latest Patents: Among his latest patents is the invention of substituted indoles and methods of use thereof. This patent focuses on compounds represented by a specific formula, which have applications in treating diseases, disorders, or conditions such as cancer. Additionally, he has developed a patent for polyacetal polymers, conjugates, and particles that emphasize pH-sensitive properties. These innovations enhance the delivery and efficacy of various agents, showcasing his dedication to addressing pressing medical challenges.

Career Highlights: Throughout his career, Lawrence has worked with notable organizations including Pfizer Corporation. His contributions to the pharmaceutical industry have been significant, reflecting his expertise in both chemical compounds and their applications in medicine.

Collaborations: During his professional journey, Lawrence has collaborated with talented individuals such as Michael John Munchhof and Gaston O Daumy. These partnerships have played a vital role in advancing his research and broadening the impact of his inventions.

Conclusion: Lawrence Alan Reiter stands out as a pivotal figure in the realm of innovation, particularly in pharmaceuticals and materials science. His extensive patent portfolio and collaborations underscore his significant contributions to advancing technology that has the potential to improve healthcare outcomes globally. His ongoing work continues to inspire future innovations in various scientific fields.

This text is generated by artificial intelligence and may not be accurate.